RESCRIPTOR (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the RESCRIPTOR drug offered from KAISER FOUNDATION HOSPITALS. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
| NON-PROPRIETARY NAME: | delavirdine mesylate |
| SUBSTANCE NAME: | DELAVIRDINE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-07-06 |
| END MARKETING DATE: | 0000-00-00 |
RESCRIPTOR HUMAN PRESCRIPTION DRUG Details:
| Item Description | RESCRIPTOR from KAISER FOUNDATION HOSPITALS |
| LABELER NAME: | KAISER FOUNDATION HOSPITALS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2011-07-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0179-0096_65d41ac2-fa4e-4881-9cbe-9e96b3894638 |
| PRODUCT NDC: | 0179-0096 |
| APPLICATION NUMBER: | NDA020705 |
Other DELAVIRDINE MESYLATE Pharmaceutical Manufacturers / Labelers:
